Details for New Drug Application (NDA): 021395
✉ Email this page to a colleague
The generic ingredient in SPIRIVA is tiotropium bromide. There are eight drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the tiotropium bromide profile page.
Summary for 021395
Tradename: | SPIRIVA |
Applicant: | Boehringer Ingelheim |
Ingredient: | tiotropium bromide |
Patents: | 3 |
Pharmacology for NDA: 021395
Mechanism of Action | Cholinergic Antagonists |
Medical Subject Heading (MeSH) Categories for 021395
Suppliers and Packaging for NDA: 021395
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
SPIRIVA | tiotropium bromide | POWDER;INHALATION | 021395 | NDA | Boehringer Ingelheim Pharmaceuticals, Inc. | 0597-0075 | 0597-0075-41 | 3 BLISTER PACK in 1 CARTON (0597-0075-41) / 10 CAPSULE in 1 BLISTER PACK |
SPIRIVA | tiotropium bromide | POWDER;INHALATION | 021395 | NDA | Boehringer Ingelheim Pharmaceuticals, Inc. | 0597-0075 | 0597-0075-47 | 9 BLISTER PACK in 1 CARTON (0597-0075-47) / 10 CAPSULE in 1 BLISTER PACK |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | POWDER;INHALATION | Strength | EQ 0.018MG BASE/INH | ||||
Approval Date: | Jan 30, 2004 | TE: | AB | RLD: | Yes | ||||
Patent: | ⤷ Sign Up | Patent Expiration: | Sep 12, 2027 | Product Flag? | Substance Flag? | Delist Request? | Y | ||
Patent: | ⤷ Sign Up | Patent Expiration: | Jul 19, 2026 | Product Flag? | Substance Flag? | Delist Request? | Y | ||
Patent: | ⤷ Sign Up | Patent Expiration: | Apr 19, 2030 | Product Flag? | Y | Substance Flag? | Delist Request? |
Expired US Patents for NDA 021395
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Boehringer Ingelheim | SPIRIVA | tiotropium bromide | POWDER;INHALATION | 021395-001 | Jan 30, 2004 | ⤷ Sign Up | ⤷ Sign Up |
Boehringer Ingelheim | SPIRIVA | tiotropium bromide | POWDER;INHALATION | 021395-001 | Jan 30, 2004 | ⤷ Sign Up | ⤷ Sign Up |
Boehringer Ingelheim | SPIRIVA | tiotropium bromide | POWDER;INHALATION | 021395-001 | Jan 30, 2004 | ⤷ Sign Up | ⤷ Sign Up |
Boehringer Ingelheim | SPIRIVA | tiotropium bromide | POWDER;INHALATION | 021395-001 | Jan 30, 2004 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription